Access cutting-edge pulmonary arterial hypertension treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access pulmonary arterial hypertension specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pulmonary arterial hypertension treatment provided free
This open-label extension study will evaluate the long-term safety, tolerability and efficacy of orally inhaled seralutinib in subjects who have completed a previous seralutinib study
Sponsor: GB002, Inc.
Check if you qualify for this pulmonary arterial hypertension clinical trial in Stanford, CA
If you're searching for pulmonary arterial hypertension treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced pulmonary arterial hypertension specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.